Piper Sandler Reiterates Overweight on Doximity, Raises Price Target to $47

Doximity, Inc. Class A

Doximity, Inc. Class A

DOCS

0.00

Piper Sandler analyst Jessica Tassan reiterates Doximity (NYSE: DOCS) with a Overweight and raises the price target from $42 to $47.